Essential Thrombocythemia - 25 Studies Found
Completed |
: Exploratory Multi-centre Trial In Patients With ET Treated With XAGRID® : Essential Thrombocythaemia : 2011-05-10 : Drug: Anagrelide hydrochloride 0.5 mg hard capsules, dosing decisions will be made by the treating physi |
Recruiting |
: Polycythemia Vera, Myelofibrosis and Essential Thrombocythemia: Identification of PV, MF & ET Genes :
: Drug: CYT387 For the Part 1 dose-escalation portion of the |
Completed |
: Extension Study Evaluating the Long Term Safety and Efficacy Study of CYT387 in Primary Myelofibrosis (PMF) or Post-polycythemia Vera (PV) or Post-essential Thrombocythemia (ET) :
: Drug: Momelotinib Patients will continue receiving the same doses as assigned during the CCL09101 protoc |
Not yet recruiting |
: 18F-FLT (PET/CT) in Prefibrotic/Early Primary Myelofibrosis and Essential Thrombocythemia :
|